Bristol-Myers Squibb Co. et al. v. Canada (Attorney General) et al., (2003) 303 N.R. 63 (FCA)
Linked as:
Extract
Bristol-Myers Squibb Co. et al. v. Canada (Attorney General) et al., (2003) 303 N.R. 63 (FCA)
No longer available (Autolink)
See the full content of this document
This document cites
- Syntex (U.S.A.) L.L.C. et al. v. Canada (Minister of Health) et al., 2002 FCA 289
- Bristol-Myers Squibb Co. et al. v. Canada (Attorney General) et al., (2002) 224 F.T.R. 236 (TD)
- Merck & Co. et al. v. Canada (Attorney General) et al., (1999) 176 F.T.R. 21 (TD)
- Merck & Co. et al. v. Canada (Attorney General) et al., (2000) 254 N.R. 68 (FCA)
- Pfizer Canada Inc. et al. v. Apotex Inc. et al., (2001) 266 N.R. 371 (FCA)
